Ante Zhu1, Raymond Y Huang2, Carl-Fredrik Westin 2, Odysseas Nikas2, Anna J Ball2, E. Antonio Chiocca2, Alexandra J Golby2
1GE HealthCare Technology and Innovation Center, Niskayuna, United States of America
2Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America
Presenting Author: Carl-Fredrik Westin
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Ling AL, Solomon IH, Landivar AM, Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS, Grant J, Zhang A, Bernstock JD, Torio E, Ito H, Liu J, Shono N, Nowicki MO, Triggs D, Halloran P, Piranlioglu R, Soni H, Stopa B, Bi WL, Peruzzi P, Chen E, Malinowski SW, Prabhu MC, Zeng Y, Carlisle A, Rodig SJ, Wen PY, Lee EQ, Nayak L, Chukwueke U, Gonzalez Castro LN, Dumont SD, Batchelor T, Kittelberger K, Tikhonova E, Miheecheva N, Tabakov D, Shin N, Gorbacheva A, Shumskiy A, Frenkel F, Aguilar-Cordova E, Aguilar LK, Krisky D, Wechuck J, Manzanera A, Matheny C, Tak PP, Barone F, Kovarsky D, Tirosh I, Suvà ML, Wucherpfennig KW, Ligon K, Reardon DA, Chiocca EA. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature. 2023;623(7985):157-66. doi: 10.1038/s41586-023-06623-2. [doi]
2. Bommareddy PK, Wakimoto H, Martuza RL, Kaufman HL, Rabkin SD, Saha D. Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for ImmunoTherapy of Cancer. 2024;12(4):e008880. doi: 10.1136/jitc-2024-008880. [doi]
3. Reynaud O, Winters KV, Hoang DM, Wadghiri YZ, Novikov DS, Kim SG. Pulsed and oscillating gradient MRI for assessment of cell size and extracellular space (POMACE) in mouse gliomas. NMR Biomed. 2016;29(10):1350-63. Epub 2016/07/23. doi: 10.1002/nbm.3577. PubMed PMID: 27448059; PMCID: PMC5035213. [doi][pmid]
4. Jiang X, Dudzinski S, Beckermann KE, Young K, McKinley E, O JM, Rathmell JC, Xu J, Gore JC. MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy. J Immunother Cancer. 2020;8(1):e000328. Epub 2020/06/26. doi: 10.1136/jitc-2019-000328. PubMed PMID: 32581044; PMCID: PMC7312343. [doi][pmid]
5. Zhu A, Shih R, Huang RY, DeMarco JK, Bhushan C, Morris HD, Kohls G, Yeo DTB, Marinelli L, Mitra J, Hood M, Ho VB, Foo TKF. Revealing tumor microstructure with oscillating diffusion encoding MRI in pre-surgical and post-treatment glioma patients. Magn Reson Med. 2023;90(5):1789-801. Epub 2023/06/19. doi: 10.1002/mrm.29758. PubMed PMID: 37335831. [doi][pmid]
6. Zhu A, Michael ES, Li H, Sprenger T, Hua Y, Lee SK, Yeo DTB, McNab JA, Hennel F, Fieremans E, Wu D, Foo TKF, Novikov DS. Engineering clinical translation of OGSE diffusion MRI. Magn Reson Med. 2025;94(3):913-36. Epub 20250507. doi: 10.1002/mrm.30510. PubMed PMID: 40331336; PMCID: PMC12262058. [doi][pmid]
7. Wang X, Lan P, Wang K, Zhu A, Abad N, Guidon A, editors. Deep learning based phase correction and denoising for accurate ADC quantification. Proceeding of ISMRM 2025; 2025; Honolulu, HI, USA.
8. Lan P, Wang X, Guidon A, editors. Improved brachial plexus and c-spine DTI using deep learning-based phase correction. Proceedings of ISMRM 2025; 2025; Honolulu, HI, USA.
9. Lebel RM. Performance characterization of a novel deep learning-based MR image reconstruction pipeline. arXiv preprint arXiv:200806559. 2020.
10. Hagen T, Ahlhelm F, Reiche W. Apparent diffusion coefficient in vasogenic edema and reactive astrogliosis. Neuroradiology. 2007;49(11):921-6. doi: 10.1007/s00234-007-0272-7. [doi]